Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

C R Bard Inc (NYSE:BCR)

219.00
Delayed Data
As of May 27
 -0.58 / -0.26%
Today’s Change
167.36
Today|||52-Week Range
223.02
+15.60%
Year-to-Date
Patterson Companies (PDCO) Q4 Earnings Top, Sales Strong
May 26 / Zacks.com - Paid Partner Content
Becton, Dickinson's (BDX) MAX Vaginal Panel Gets CE Mark
May 16 / Zacks.com - Paid Partner Content
LabCorp (LH) Posts Strong Q1; Covance Synergy Continues
May 17 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close219.58
Today’s open220.00
Day’s range218.75 - 220.15
Volume454,880
Average volume (3 months)525,479
Market cap$16.1B
Dividend yield0.44%
Data as of 4:02pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-52.93%
Earnings growth (this year)+11.70%
Earnings growth (next 5 years)+10.18%
Revenue growth (last year)+2.78%
P/E ratio147.9
Price/Sales4.18
Price/Book11.09

Competitors

 Today’s
change
Today’s
% change
EWEdwards Lifesciences...+0.61+0.61%
ZBHZimmer Biomet Holdin...+0.58+0.47%
WSTWest Pharmaceutical ...+0.88+1.19%
DXCMDexCom Inc+2.14+3.39%
Data as of 4:02pm ET, 05/27/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)$2.47
Annual revenue (last year)$3.4B
Annual profit (last year)$133.5M
Net profit margin3.91%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Tim M. Ring
President, Chief Operating Officer &
Director
John H. Weiland
Corporate headquarters
Murray Hill, New Jersey

Forecasts

Partner Offers

Search for Jobs